Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
[3H]Dopamine ([3H]DA) Uptake Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:47 Active, 47 Activity ≤ 1 µM, 47 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
[3H]Dihydrotetrabenazine ([3H]DTBZ) Binding Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:49 Active, 18 Activity ≤ 1 µM, 53 Tested
[3H]DA and [3H]5-HT Uptake Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:90 Active, 90 Activity ≤ 1 µM, 91 Tested
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Uptake, Dopamine - Antagonist Eurofins Panlabs panel
Transporter, Norepinephrine (NET) Eurofins Panlabs panel
Transporter, Dopamine (DAT) Eurofins Panlabs panel
NEUP/H Eurofins SafetyScreen44 (BI)
DATRANS/HUM Eurofins SafetyScreen44 (BI)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on